Team:TU-Munich/Project/Bioaccumulation

In general bioaccumulation is a versatile and ambiguous concept to be defined. “General term describing a process by which chemicals are taken up by an organism either directly from exposure to a contaminated medium or by consumption of food containing the chemical.” is the definition of bioaccumulation of the U.S. Environmental Protection Agency, 2010. The majority of definitions is aimed at the vicious circle of the predator-prey relationship caused by the bioaccumulation shows the build up of persistent chemicals such as DDT, PBC or dioxins in aquatic and terrestrial organisms. Health problems in humans, the survival of some affected populations and overall biodiversity in aquatic and terrestrial ecosystems are at risk and a result of the consume and the accumulation of persistent chemicals along the food chain (see figure 1 ). The Minamata catastrophe 1950 substantiates the result of mecury poisoning: the Chisso Corporation in Minamata released untreated effluent containing methylmercurychloride into Minamata Bay.

In Respect to Bioaccumulation we propose the employment of transgenic moos (Physcomitrella patens ) to produce effectors for enzymatic specific binding of pollutants additional to the biodegradation method for the development of a functional wastewater filter system which convert noxious critical substances in wastewater into non-hazardous compounds .Bioaccumulation is a possibility to remove xenobiotics from the environment by binding them to a protein that has been designed for this purpose (see figure 2). There are a broad range of natural as well as engineered binding proteins available. Natural binding proteins act as a model and initiator in design of new artificial binding proteins regarding research in different fields of biotechnology. Lipocalins, natural binding proteins, as base and scaffold for the design of anticalins confirms the popularity of bioaccumulated proteins in red biotechnology . The role of Fibrillin in the abscisic acid-mediated photoprotection shows an example of functioned bioaccumulation in a plant . The most commonly known binding proteins are antibodies which defend mammals against pathogens and toxins. Beside these natural binding proteins and anticalins there are more and more designed binding proteins such as Affibodies derived from the z-domain of the antibody-binding protein A (Ref) and DARPins that are based on an ankyrin scaffold .Critical substances such as Bisphenol A known as an endocrine disrupter which can mimic endrogen and the anti-inflammatory drug used as analgesic Diclofenac could accumulate by our physco filter. The last effects in contrast to the negative health effects developed from Bisphenol A ecological effects like on freshwater fish species. The localization of the effectors is exclusive membrane associated in contrast to the cytoplasmatic or secretory localization by biodegraded effectors.

Figure 1: General principle of our bioaccumulation

The Fluorescein binding Anticalin FluA

Figure 2:Structure of FluA with its ligand and comparison of ligand

There are a broad range of natural as well as engineered binding proteins availible. The most commonly known binding proteins are antibodies which defend mammals against pathogens and toxins. Beside these natural binding proteins there are more and more designed binding proteins such as (1) Anticalins based on a lipocalin scaffold [[http://www.ncbi.nlm.nih.gov/pubmed/10051566 Beste et al., 1999], [http://www.ncbi.nlm.nih.gov/pubmed/16307475 Vopel et al., 2005]], (2) Affibodies derived from the z-domain of the antibody-binding protein A (Ref) and (3) DARPins that are based on an ankyrin scaffold. [...] reshaping of the binding pocket by amino acid substitutions to bind different ligand. Bilin-binding-protein binding bilin was reshaped to bind fluorescein. Idea is to apply technologies developed for the red biotechnology for medical purposes in the context of bioremediation.Possiblity ot develop binding proteins against nearly all chemical structures with comparabale size. Created trangenic moss PF-15 with the fluorescein binding anticalin fluA on the extracellular part of the receptor.

Glutathione S-transferase

Figure 1: GST, Glutathion Gleichgewicht, Gluthion conjugation, Reaction of monochlorobimane

• General principle of glutathion conjugation
• Trap mechanism: chemical compound is much more soluble after conjugation and becomes transported into the vacuole.
• Already a natural mechanism in plants. Enzymes might be limited and genetic engineering can focuss this existing problem on specific chemical compounds.
• Transgenic moss created
• Usage of an existing BioBrick <partinfo>BBa_K620000</partinfo>
• Assay is the conjugation of Glutathion to Monochlorobimane which becomes fluorescent after conjugation.

Protein Phosphotase 1 - A molecular mop for Microcystin

[[File:TUM13 Physco-lifecycle.png|thumb|right|350px| Figure 1: Algenblüte, Microcystin, PP1 und Microcystein]

• From a collaboration with Dundee iGEM Team
• Enzyme (phosphatase) derived

Text

1. http://www.ncbi.nlm.nih.gov/pubmed/10051566 Beste et al., 1999 Beste G, Schmidt FS, Stibora T, Skerra A. (1999) Small antibody-like proteins with prescribed ligand specificities derived from the lipocalin fold. PNAS, 96(5):1898-903.
2. http://www.ncbi.nlm.nih.gov/pubmed/16307475 Vopel et al., 2005 Vopel S, Mühlbach H, Skerra A. (2005) Rational engineering of a fluorescein-binding anticalin for improved ligand affinity. Biol. Chem., 386(11):1097-104.
3. http://www.ncbi.nlm.nih.gov/pubmed/9255793 Nord et al., 1997 Nord K, Gunneriusson E, Ringdahl J, Ståhl S, Uhlén M, Nygren PA. (1997) Binding proteins selected from combinatorial libraries of an α-helical bacterial receptor domain. Nature Biotech. 15(8):772-7.